Inflammatory diseases are characterized by excessive inflammation, which poses significant health challenges globally. Over the last two decades, epidemiological studies have highlighted a rising prevalence of such conditions and an increased reliance on anti-inflammatory medications. Current treatments largely focus on symptom management rather than addressing the root causes, often due to a lack of understanding of the underlying molecular mechanisms and specific therapeutic targets. This gap in knowledge necessitates a thorough investigation into the molecular underpinnings and potential biomarkers that could lead to more effective treatments.
This Research Topic aims to delve into the molecular mechanisms, identify novel therapeutic biomarkers, and foster innovations in anti-inflammatory drug therapies for various inflammatory diseases including osteoarthritis, tendinopathy, and inflammatory bowel disease. It seeks to advance our understanding and enhance protection against these conditions, while also exploring new perspectives for clinical treatment.
To further our understanding in this crucial area, we welcome contributions across several formats, from original research to reviews and systematic analyses. Pertinent themes include:
-Epigenetic regulation and novel therapeutic targets in inflammatory diseases
-Molecular mechanisms underlying inflammatory diseases
-Bioinformatics approaches coupled with experimental verification in inflammatory research
-Precision therapies for treating inflammatory conditions
-Pharmacogenomics and lab validation in anti-inflammatory drug discovery
-Analysis of clinical data pertaining to inflammatory diseases
Inflammatory diseases are characterized by excessive inflammation, which poses significant health challenges globally. Over the last two decades, epidemiological studies have highlighted a rising prevalence of such conditions and an increased reliance on anti-inflammatory medications. Current treatments largely focus on symptom management rather than addressing the root causes, often due to a lack of understanding of the underlying molecular mechanisms and specific therapeutic targets. This gap in knowledge necessitates a thorough investigation into the molecular underpinnings and potential biomarkers that could lead to more effective treatments.
This Research Topic aims to delve into the molecular mechanisms, identify novel therapeutic biomarkers, and foster innovations in anti-inflammatory drug therapies for various inflammatory diseases including osteoarthritis, tendinopathy, and inflammatory bowel disease. It seeks to advance our understanding and enhance protection against these conditions, while also exploring new perspectives for clinical treatment.
To further our understanding in this crucial area, we welcome contributions across several formats, from original research to reviews and systematic analyses. Pertinent themes include:
-Epigenetic regulation and novel therapeutic targets in inflammatory diseases
-Molecular mechanisms underlying inflammatory diseases
-Bioinformatics approaches coupled with experimental verification in inflammatory research
-Precision therapies for treating inflammatory conditions
-Pharmacogenomics and lab validation in anti-inflammatory drug discovery
-Analysis of clinical data pertaining to inflammatory diseases